# PET/MRI of Primary Sclerosing Cholangitis

> **NCT06252610** · — · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 10 (estimated)

## Conditions studied

- PSC

## Interventions

- **DRUG:** Radiotracer Injection
- **DRUG:** Contrast Media, Magnetic Resonance
- **DIAGNOSTIC_TEST:** Imaging

## Key facts

- **NCT ID:** NCT06252610
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-10
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06252610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06252610, "PET/MRI of Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06252610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*